Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biocryst Pharma Inc (NQ: BCRX ) 4.160 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,309,942 Open 4.210 Bid (Size) 4.050 (1) Ask (Size) 4.240 (5) Prev. Close 4.160 Today's Range 4.110 - 4.260 52wk Range 4.030 - 9.065 Shares Outstanding 185,583,896 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects March 01, 2024 These penny stocks offer triple digit returns to investors right now but not many investors are aware of them. Via InvestorPlace BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript February 26, 2024 BCRX earnings call for the period ending December 31, 2023. Via The Motley Fool Topics Earnings Exposures Financial Performance YTD -31.47% -31.47% 1 Month -16.97% -16.97% 3 Month -23.67% -23.67% 6 Month -23.81% -23.81% 1 Year -45.41% -45.41% More News Read More What's Going On With BioCryst Stock After Earnings? February 26, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session February 26, 2024 Via Benzinga Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session February 26, 2024 Via Benzinga Topics Stocks Exposures US Equities A Preview Of BioCryst Pharma's Earnings February 23, 2024 Via Benzinga What's Going On With BioCryst Pharmaceuticals Stock? January 08, 2024 Via Benzinga Where BioCryst Pharma Stands With Analysts November 20, 2023 Via Benzinga Earnings Scheduled For February 26, 2024 February 26, 2024 Via Benzinga What 7 Analyst Ratings Have To Say About BioCryst Pharma September 25, 2023 Via Benzinga Analyst Expectations for BioCryst Pharma's Future May 04, 2023 Via Benzinga Why BioCryst Pharmaceuticals Stock Is Soaring Today May 03, 2023 Via The Motley Fool Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Via Benzinga Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 06, 2023 Via Benzinga BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth May 03, 2023 Via Benzinga BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript November 03, 2023 Via The Motley Fool Topics Earnings Exposures Financial Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 September 18, 2023 Via Benzinga 3 Magnificent Growth Stocks to Buy on the Dip August 28, 2023 Via The Motley Fool Recap: BioCryst Pharma Q1 Earnings May 03, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 August 04, 2023 Via Benzinga BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript August 03, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023 July 13, 2023 Via Benzinga BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript May 03, 2023 Via The Motley Fool Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today? April 18, 2023 Via InvestorPlace Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday April 18, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.